HCPCS Level II · Drugs administered other than oral method
J1171Injection, hydromorphone, 0.1 mg
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J1171
J1171 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, hydromorphone, 0.1 mg.
It was added to HCPCS effective 10/01/2024, and its current record took effect 01/01/2025.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Inj, hydromorphone, 0.1 mg
- Date added
- 10/01/2024
- Action effective
- 01/01/2025
- BETOS
- O1E
Related J11xx codes
- J1100Injection, dexamethasone sodium phosphate, 1 mg
- J1105Dexmedetomidine, oral, 1 mcg
- J1110Injection, dihydroergotamine mesylate, per 1 mg
- J1120Injection, acetazolamide sodium, up to 500 mg
- J1130Injection, diclofenac sodium, 0.5 mg
- J1160Injection, digoxin, up to 0.5 mg
- J1162Injection, digoxin immune fab (ovine), per vial
- J1163Injection, diltiazem hydrochloride, 0.5 mg
- J1164Injection, diltiazem hydrochloride in 0.72% sodium chloride, 0.5 mg
- J1165Injection, phenytoin sodium, per 50 mg
- J1180Injection, dyphylline, up to 500 mg
- J1190Injection, dexrazoxane hydrochloride, per 250 mg
Common questions about J1171
Is HCPCS J1171 still valid?
- Yes. J1171 is active in the CMS October 2026 HCPCS file.
Does Medicare cover J1171?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.